AtonRa Partners’s Exact Sciences EXAS Stock Holding History

AtonRa Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$667K	Sell	9,013 -846	-9%	-$55.5K	1.33%	16
2023 Q3	$673K	Sell	9,859 -256	-3%	-$21.7K	1.41%	11
2023 Q2	$950K	Sell	10,115 -1,415	-12%	-$110K	1.47%	16
2023 Q1	$782K	Sell	11,530 -1,622	-12%	-$104K	1.14%	24
2022 Q4	$651K	Buy	13,152 +738	+6%	+$30.2K	0.83%	54
2022 Q3	$403K	Buy	12,414 +3,250	+35%	+$134K	0.4%	104
2022 Q2	$361K	Sell	9,164 -972	-10%	-$52K	0.33%	115
2022 Q1	$709K	Sell	10,136 -1,694	-14%	-$124K	0.39%	93
2021 Q4	$921K	Buy	11,830 +588	+5%	+$51.9K	0.32%	96
2021 Q3	$1.07M	Buy	11,242 +1,473	+15%	+$156K	0.36%	95
2021 Q2	$1.21M	Buy	9,769 +109	+1%	+$13K	0.45%	81
2021 Q1	$1.27M	Buy	+9,660	New	+$1.32M	0.57%	73

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AtonRa Partners's EXAS Position: Q4 2023 in Review

AtonRa Partners reduced its Exact Sciences (EXAS) stake by 8.6% in Q4 2023, selling an estimated $55.5K and leaving 9,013 shares worth $667K. The position accounts for 1.33% of the portfolio, ranked #16.

AtonRa Partners first reported a position in EXAS in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.27M in Q1 2021. 646 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

AtonRa Partners held 9,013 shares of Exact Sciences worth $667K as of Q4 2023.
AtonRa Partners sold 846 Exact Sciences shares in Q4 2023, an estimated $55.5K.
Exact Sciences made up 1.33% of AtonRa Partners's portfolio in Q4 2023, its #16 holding.
AtonRa Partners first reported a position in Exact Sciences in Q1 2021 and has held it in 12 quarters since.
AtonRa Partners's Exact Sciences position peaked at $1.27M in Q1 2021.
646 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.